board of directors
danielle shiv
Chair of the Board
Danielle Shiv is a strategic fundraising consultant working across all sectors of the nonprofit space. Danielle specializes in capital campaigns, managing nonprofits' pipelines of high net worth individuals to maximize the impact of a donor's gift on the organization.
Prior to working alongside nonprofits, Danielle worked in New York City's advertising scene, creating content and connecting with customers.
Danielle earned her Master's in Learning Sciences from Northwestern University, and her BA in Sociology from Oberlin College.
In her free time, Danielle can be found trying new restaurants or working on an art project.
michelle woodhill
Board Member
Michelle Woodhill is the Chief Development Officer at Tower Cancer Research Foundation. Prior to Tower, Michelle worked at the Dr. Susan Love Research Foundation where she met many Breasties and patient advocates.
Michelle, a Southern California native, is an experienced fundraising executive in healthcare focusing on major gifts, corporate and foundation giving, and special events.
She has worked in the nonprofit and public interest sector for over 15 years, bringing keen insights into the diverse corporate and private philanthropic landscape of the United States. In her free time, Michelle enjoys traveling with her husband and two children, taking pilates and yoga, and trips to Disneyland.
dr. isaac chan
Board Member
Dr. Isaac Chan is a physician-scientist dedicated to eliminating mortality associated with metastatic breast cancer. He currently sees patients and runs a research lab as an Assistant Professor at University of Texas Southwestern Medical Center in Dallas. He received his bachelor’s degree in biomedical engineering at Duke University, followed by a combined M.D. and Ph.D. degree at University of North Carolina in genetics and molecular signaling. He continued training in internal medicine at Boston University and medical oncology at Johns Hopkins University. His research has been internationally recognized and his lab focuses on using novel gene therapies to end metastatic disease.